Literature DB >> 15968729

Hepatosplenic gammadelta T-cell lymphoma.

Shuan-Zeng Wei1, Tong-Hua Liu, De-Tian Wang, Jin-Ling Cao, Yu-Feng Luo, Zhi-Yong Liang.   

Abstract

AIM: To investigate the clinicopathologic characteristics, immunophenotype and TCR gene rearrangements of hepatosplenic T-cell lymphoma in eight Chinese patients.
METHODS: Eight Chinese patients with hepatosplenic gammadelta T-cell lymphomas were studied. Hematoxylin-eosin-stained slides and clinical histories were reviewed. We also carried out immunohistochemical staining for CD3, CD4, CD8, CD20, CD43, CD56, CD79a, UCHL-1, and TCR gammadelta. Rearrangements of TCR gamma and delta chain genes were also studied.
RESULTS: The spleens were enlarged and the cut surfaces were homogeneous and red-purple in color without identifiable gross lesions or enlarged hilar lymph nodes. Histologically, lymphoma cells infiltrated the cords of Billroth and often packed the sinuses. Liver biopsy showed lymphoma cell infiltrations in the sinusoids, and three cases showed involvements of the portal tracts. Immunohistochemically lymphoma cells were positive for CD3, CD43, and CD56 in all cases. Four of eight cases were positive for CD8, and all cases were negative for CD4 (6/6). Monoclonal rearrangements of TCR gamma gene were demonstrated by PCR analysis in five out of the eight cases. TCR delta gene rearrangements were detected in six out of the eight cases, which demonstrated single bands on PAGE gel, and the amplification products in two cases were confirmed by sequencing.
CONCLUSION: The clinicopathology of hepatosplenic gammadelta T-cell lymphoma in Chinese patients is similar to what was previously reported except that the splenomegaly is not so massive, and CD8 is positive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968729      PMCID: PMC4316025          DOI: 10.3748/wjg.v11.i24.3729

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.

Authors:  G K Przybylski; H Wu; W R Macon; J Finan; D G Leonard; R E Felgar; J A DiGiuseppe; P C Nowell; S H Swerdlow; M E Kadin; M A Wasik; K E Salhany
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis.

Authors:  S Signoretti; M Murphy; M G Cangi; P Puddu; M E Kadin; M Loda
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

3.  T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry.

Authors:  W R Macon; K E Salhany
Journal:  Am J Clin Pathol       Date:  1998-05       Impact factor: 2.493

4.  Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples.

Authors:  D A Arber; R M Braziel; A Bagg; K E Bijwaard
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

5.  Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma.

Authors:  J M Muche; A Lukowsky; K Asadullah; S Gellrich; W Sterry
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

Review 6.  Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990.

Authors:  E Weidmann
Journal:  Leukemia       Date:  2000-06       Impact factor: 11.528

Review 7.  Gammadelta T-cell lymphomas.

Authors:  Philippe Gaulard; Karim Belhadj; Felix Reyes
Journal:  Semin Hematol       Date:  2003-07       Impact factor: 3.851

Review 8.  Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

Authors:  Karim Belhadj; Felix Reyes; Jean-Pierre Farcet; Herve Tilly; Christian Bastard; Regis Angonin; Eric Deconinck; Frederic Charlotte; Veronique Leblond; Eric Labouyrie; Pierre Lederlin; Jean-Francois Emile; Beatrice Delmas-Marsalet; Bertrand Arnulf; Elie-Serge Zafrani; Philippe Gaulard
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

  8 in total
  3 in total

1.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

2.  Gamma/delta T-cell lymphoma in a dog.

Authors:  Petra Borska; Martin Faldyna; Jan Blatny; Lenka Leva; Monika Vejrostova; Jaroslav Doubek; Peter F Moore
Journal:  Can Vet J       Date:  2009-04       Impact factor: 1.008

3.  Hepatosplenic gamma-delta T-cell lymphoma in a female patient after delivery.

Authors:  Marjana Glaser; Aleš Goropevšek; Rajko Kavalar; Andrej Glaser
Journal:  Hematol Rep       Date:  2012-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.